Metraipolis › archive › dc_59ffc2056faf

Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition Strategy — Europe PMC PMID:41011713

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41011713
DOI
10.3390/molecules30183821
License (as archived)
solo-consultazione
Archived
2026-11-09T20:38:06.781Z
SHA-256 of the archived text
8d3614b5d929fa0274b2b0afb639c2c5904aa667ee50fb9c864fa321a28adc1e
Stable URL of this page
https://metraipolis.com/documento/dc_59ffc2056faf

How to cite

Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition Strategy — Europe PMC PMID:41011713 — Europe PMC (en), https://europepmc.org/article/MED/41011713 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_59ffc2056faf (Metraipolis archive dc_59ffc2056faf, sha256 8d3614b5d929fa0274b2b0afb639c2c5904aa667ee50fb9c864fa321a28adc1e)
BibTeX
@misc{dc59ffc2056faf,
  title = {Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition Strategy — Europe PMC PMID:41011713},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41011713},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_59ffc2056faf; sha256 8d3614b5d929fa0274b2b0afb639c2c5904aa667ee50fb9c864fa321a28adc1e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41011713. Agents can read the archived copy with the MCP tool read_document.